SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-14-053526
Filing Date
2014-02-14
Accepted
2014-02-14 11:34:34
Documents
1
Group Members
AP V GMBH & CO. KGAPAX EUROPE V GP CO. LTDAPAX EUROPE V GP, L.P.APAX EUROPE V-1, L.P.APAX EUROPE V-2, L.P.APAX EUROPE V-A, L.P.APAX EUROPE V-B, L.P.APAX EUROPE V-C GMBH & CO. KGAPAX EUROPE V-D, L.P.APAX EUROPE V-E, L.P.APAX EUROPE V-F, C.V.APAX EUROPE V-G

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 d675288dsc13ga.htm SC 13G/A 228710
  Complete submission text file 0001193125-14-053526.txt   230823
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Subject) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48769 | Film No.: 14612772
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 33 JERMYN STREET LONDON X0 SW1Y 6DN 011-44-207-872-6300
APAX PARTNERS EUROPE MANAGERS LTD (Filed by) CIK: 0001219510 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G/A